Adagene Inc. (NASDAQ: ADAG) insider reports 2.39M shares, 5.1% stake
Rhea-AI Filing Summary
Adagene Inc. Schedule 13G filing reports that Jorey Chernett beneficially owned 2,389,060 Ordinary shares as of the close of business on March 17, 2026, representing 5.1% of the class based on 58,914,087 Ordinary Shares outstanding as of June 30, 2025, per the issuer's prospectus.
The cover disclosure notes the CUSIP 005329107 is assigned to the issuer's ADSs quoted on NASDAQ under the symbol ADAG, and that each ADS represents one and one quarter Ordinary Share. The filing is a beneficial ownership report by the reporting person, signed on March 18, 2026.
Positive
- None.
Negative
- None.
Insights
Holder reports a single beneficial stake of 5.1%, a disclosure-level ownership
Adagene's filing shows a beneficial ownership position of 2,389,060 Ordinary shares held by the reporting person as of March 17, 2026. The percentage uses the issuer's stated outstanding share count of 58,914,087 as of June 30, 2025.
Such Schedule 13G disclosures inform governance and voting landscapes; subsequent filings could update percent ownership if outstanding share counts change or further acquisitions/dispositions occur. Corporate records and proxy disclosures will reflect any voting implications tied to this stake.
Filing is a routine beneficial ownership disclosure under Schedule 13G
The report identifies the filing person, address, citizenship, and exact share counts with sole voting and dispositive power of 2,389,060 shares. It also cites the prospectus figure for outstanding shares, anchoring the 5.1% calculation.
From a compliance view, the filing meets identification and signature elements. Any material change in holdings or control would require an amended filing consistent with federal disclosure rules; timing of such amendments is governed by Schedule 13G/13D provisions.